Similar articles

• Absorption and antidysrhythmic activity of oral disopyramide phosphate after acute myocardial infarction.

  Kumana CR, Rambihar VS, Willis K, Gupta RN, Tanser PH, Cairns JA, Wildeman RA, Johnston M, Johnson AL, Gent M. Kumana CR, et al. Br J Clin Pharmacol. 1982 Oct;14(4):529-37. doi: 10.1111/j.1365-2125.1982.tb02024.x. Br J Clin Pharmacol. 1982. PMID: 6753888 Free PMC article. Clinical Trial.
• Disopyramide in the treatment and prevention of arrhythmias following myocardial infarction.

  Zainal N, Jennings G, Jones B, Model D, Turner P, Besterman EM, Kidner PH. Zainal N, et al. J Int Med Res. 1976;4(1 Suppl):71-3. J Int Med Res. 1976. PMID: 799982 Clinical Trial. No abstract available.
• Effects of disopyramide and aprindine on arrhythmias after acute myocardial infarction.

  Pouleur H, Chaudron JM, Reyns P. Pouleur H, et al. Eur J Cardiol. 1977 Jul;5(5):397-404. Eur J Cardiol. 1977. PMID: 330168 Clinical Trial.
• Disopyramide--a review.

  Ankier SI, Carmichael DJ, Kidner PH. Ankier SI, et al. Scott Med J. 1977 Oct;22(4):314-9. doi: 10.1177/003693307702200424. Scott Med J. 1977. PMID: 337485 Review. No abstract available.
• [Clinical pharmacology of disopyramide].

  Rewerski W, Dorociak A, Walczak F, Dobiasz A. Rewerski W, et al. Pol Tyg Lek. 1980 Jul 21;35(29):1109-12. Pol Tyg Lek. 1980. PMID: 7001399 Review. Polish. No abstract available.